Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bioaerosol

ABSTRACT: Bioaerosol Genome sequencing

PROVIDER: PRJNA808868 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18086452_1.fastq.gz	Fastqsanger.gz
	SRR18086452_2.fastq.gz	Fastqsanger.gz
	SRR18086453_1.fastq.gz	Fastqsanger.gz
	SRR18086453_2.fastq.gz	Fastqsanger.gz
	SRR18086454_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 26

Similar Datasets

bioaerosol

Project description:bioaerosol Raw sequence reads

| PRJNA625375 | ENA

bioaerosol

Project description:bioaerosol Raw sequence reads

| PRJNA897829 | ENA

bioaerosol

Project description:Emission of primary bioaerosol particles from Baltic Sea water

| PRJEB49421 | ENA

Murine Legionella pneumophilaInfection by Bioaerosol Inhalation in a Madison Aerosol Chamber Leads to Similar Disease Outcomes and Host Transcriptomic Responses as Intranasal Inoculation While Allowing for Bioaerosol Analysis

Project description:Legionnaire’s Disease is a growing concern for the United States and Europe, with disease incidences rising 6-fold since 2002. These recorded cases are increasingly associated with antibiotic resistant Legionella pneumophila, the causative agent of Legionnaire’s Disease and overall Legionellosis. With this, the need to study L. pneumophilainfections has never been greater. Current methodology for Legionella pneumophila infection studies often revolves around either artificial administration using intranasal or intratracheal delivery, semi-authentic delivery using bioaerosols and individual delivery systems (i.e. nose cones), or the burgeoning field of authentic exposure scenarios using aerosol generating showerhead devices. Here, we developed an alternative method using a Madison Aerosol Chamber as a means of generating and delivering bioaerosols in mice. We show that bioaerosol delivery using the Aerosol Exposure Chamber is very effective at exposing mice to various doses of L. pneumophila. RNASeq analyses revealed a robust immune response to bioaerosol delivered L. pneumophila comprising of activations of classical markers of infection and inflammation, including Cxcl and Ccl family genes and Il-1β. Similar gene expression profiles were observed when animals were intranasally exposed to L. pneumophila. Intranasal delivery resulted in a shorter duration of activation of several genes, indicating a lack of realistic infection response. Taken together, this evidence shows that our system delivers similar, if not better, results than intranasal inoculation while allowing researchers to study bioaerosol generation and delivery mechanisms simultaneously, critical factors for studying Legionella pneumophila infection. Such a new approach will allow for more accurate investigations to understand the effects of inhaling to Legionella contaminated drinking water.

2023-10-01 | GSE241094 | GEO

Capturing the Aerobiome: Application of Polyurethane Foam Disk Passive Samplers for Bioaerosol Monitoring

Project description:PU Foam Disk Passive Samplers for Bioaerosol Monitoring

| PRJEB71037 | ENA

Bioaerosol sequencing

Project description:Bacterial and fungal sequencing of bioaerosols from pig farms

| PRJEB29770 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Advancing DNA extraction techniques of atmospheric bioaerosol samples for sequencing with Nanopore without amplification

Project description:Advancing DNA extraction techniques of atmospheric bioaerosol samples for sequencing with Nanopore without amplification: evaluating purification strategies.

| PRJEB76246 | ENA

Project description:Bioaerosol metagenome

| PRJNA824984 | ENA

Project description:Bioaerosol metagenome

| PRJNA495624 | ENA